Monkeypox Is A Different Drug Development Ballgame From COVID-19

Company Shifts Focus To Randomized Trials For EUA

 
• By Alaric DeArment

SIGA chief scientific officer Dennis Hruby spoke with Scrip about how the company is developing its drug, Tpoxx, to address the monkeypox outbreak.

SIGA's smallpox drug, Tpoxx, is moving through multiple clinical trials for monkeypox worldwide • Source: Shutterstock

More from Clinical Trials

More from R&D